Ovarian Cancer Treatment Drugs Markets in China

Published: Jan, 2014 | Pages: 253 | Publisher: Asia Market Information & Development Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

 Table Of Contents



 I. INTRODUCTION  

Report Scope and Methodology  
Executive Summary  

 II. BUSINESS ENVIRONMENT  
  
  Economic Outlook
  
Key Economic Indicators   
Industrial Output  
Population and Labor  
Foreign Investment   
Foreign Trade 
 
  Financial and Tax Regulations

Banking System and Regulations  
Foreign Exchange   
Taxes, Tariff and Custom Duties  

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS  

Ovarian Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Ovarian Cancer Treatment Drugs Sales Volume 
Major Producer Facility Locations    
Major Producers' Sales Volume and Market Share
    Paclitaxel
    Platinum Anticancer Drugs
    Fluoropyrimidines
    Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH
Labor Cost  
Potential Entrants  
Major Distributors  
Major Foreign Investment  
Technology Development  


IV.  OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  
Overview

Ovarian Cancer Treatment Drugs Sales Volume 

Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug 
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH?RH

Ovarian Cancer Treatment Drugs Import 

Chemotherapeutic Drug
Anthracycline Antibiotics
Fluoropyrimidines
Paclitaxel
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug 
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH?RH

Pricing Trend 





V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

Ovarian Cancer Treatment Drugs Markets Outlook Overview 
Government Regulation
Health Care Insurance Industry Overview 
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
    

 VI. MARKET ENTRY CHANNELS  

  China Market Entry Overview
China's Distribution System
Ovarian Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

China's Market Entry
                     Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

   
VII.     OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY  

Ovarian Cancer Treatment Drugs Producer Profiles and Directory  
  
    





































List Of Tables


 I. INTRODUCTION  

Economic Outlook Summary  

 II. BUSINESS ENVIRONMENT  
 
Key Economic Indicators 
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade


III.     OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS  


Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
Major Foreign Investments in China


IV.      OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND  

Ovarian Cancer Treatment Drugs Sales Volume 
Chemotherapeutic Drug Major Producer and Their Market Share
Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification

Chemotherapeutic Drug Major Producer and Their Market Share
Paclitaxel Major Producer and Their Market Share
Fluoropyrimidines Major Producer and Their Market Share
Anthracycline Antibiotics Major Producer and Their Market Share
Platinum Anticancer Drugs Major Producer and Their Market Share
Targeted Therapy Drug Major Producer and Their Market Share 
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Therapertic Antibody Major Producer and Their Market Share
Small Molecules Drug Major Producer and Their Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Major Producer and Their Market Share 
Anti-estrogens Major Producer and Their Market Share 
Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share 
LH?RH Major Producer and Their Market Share
Ovarian Cancer Treatment Drugs Import 




V.  OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK   

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits 

 













List Of Charts


I. INTRODUCTION

Ovarian Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China's GDP and Growth Rate 
Industrial Output by Ownership 
China's Imports and Exports 


III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

                   Chemotherapeutic Drug Market Share by Drugs Classification
Targeted Therapy Drug Market Share by Drugs Classification
Endocrine Therapy Drug Market Share by Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Sales Volume and Market Share
Chemotherapeutic Drug Sales Volume by Drugs Classification
Paclitaxel Sales Volume and Market Share
Fluoropyrimidines Sales Volume and Market Share
Anthracycline Antibiotics Sales Volume and Market Share
Platinum Anticancer Drugs Sales Volume and Market Share
Targeted Therapy Drug Sales Volume and Market Share
Targeted Therapy Drug Sales Volume by Drugs Classification
Therapertic Antibody Sales Volume and Market Share
Small Molecules Drug Sales Volume and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share

Endocrine Therapy Drug Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume by Drugs Classification
Anti-estrogens Sales Volume and Market Share
Progesterone Sales Volume and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
LH?RH Sales Volume and Market Share
Ovarian Cancer Treatment Drugs Import 
Chemotherapeutic Drug Import and Market Share
Chemotherapeutic Drug Import by Drugs Classification
Paclitaxel Import and Market Share
Anthracycline Antibiotics Import and Market Share
Fluoropyrimidines Import and Market Share
Placlitaxel Anticancer Drugs Import and Market Share
Platinum Anticancer Drugs Import and Market Share
Targeted Therapy Drug Import and Market Share
Targeted Therapy Drug Import by Drugs Classification
Therapertic Antibody Import and Market Share
Small Molecules Drug Import and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
Endocrine Therapy Drug Import and Market Share
Endocrine Therapy Drug Import by Drugs Classification
Anti-estrogens Import and Market Share
Progesterone Import and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
LH?RH Import and Market Share  


VI. MARKETING STRATEGIES

China's Distribution Channel